COVID-19 PNEUMONIA
Clinical trials for COVID-19 PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new COVID-19 PNEUMONIA trials appear
Sign up with your email to follow new studies for COVID-19 PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial aims to stop COVID's lasting lung damage
Disease control OngoingThis study is testing whether the drug sirolimus can prevent permanent lung scarring (fibrosis) in people hospitalized with severe COVID-19 pneumonia. Hospitalized patients will be randomly assigned to receive different doses of sirolimus or standard care alone. Researchers will …
Matched conditions: COVID-19 PNEUMONIA
Phase: PHASE2, PHASE3 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
AI listens for COVID: new tech aims to spot illness with a scan
Diagnosis OngoingThis study is testing new, non-invasive devices that listen to body sounds to detect COVID-19, flu, and RSV. It involves 300 adults, both with and without symptoms, who are already getting standard screening tests at a military medical center. The goal is to see if these AI-power…
Matched conditions: COVID-19 PNEUMONIA
Sponsor: The Geneva Foundation • Aim: Diagnosis
Last updated Mar 23, 2026 15:18 UTC